FDA Finalizes Guidance On Abuse-Deterrent Narcotics
The U.S. Food and Drug Administration on Wednesday finalized its guidance urging drugmakers to devise abuse-deterrent versions of opioid medications, a move that follows criticism by lawmakers and consumer groups about...To view the full article, register now.
Already a subscriber? Click here to view full article